Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Joachim Hipp"'
Autor:
Andreas Straube, Gregor Broessner, Charly Gaul, Xenia Hamann, Joachim Hipp, Torsten Kraya, Lars Neeb
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-11 (2023)
Abstract Background Monoclonal antibodies targeting the CGRP pathway are effective and safe for prophylactic treatment of episodic (EM) and chronic migraine (CM). In case of treatment failure of a CGRP pathway targeting mAb, physician has to decide w
Externí odkaz:
https://doaj.org/article/cf58aa4c556a4b3aaab774d818590c9d
Autor:
Christian Geßner, Thomas Fietz, Christoph Losem, Andreas Lück, Holger Schulz, Beate Niemeier, Matthias Groschek, Henning Eschenburg, Rudolf Weide, Albrecht Kretzschmar, Nikolaj Frost, Joachim Hipp, Johanna Harde, Christiane D. Matillon, Sina Grebhardt, Karin Potthoff
Publikováno v:
Current Medical Research and Opinion. 38:2191-2199
Real-world evidence on the application of the granulocyte colony-stimulating factor lipegfilgrastim for the reduction of chemotherapy-induced neutropenia and febrile neutropenia (FN) is limited. The NADIR study aimed to evaluate effectiveness and saf
Autor:
Andreas Straube, Gregor Brössner, Charly Gaul, Xenia Hamann, Joachim Hipp, Torsten Kraya, Isabel Schauerte, Lars Neeb
Publikováno v:
Thursday, April 27.
Publikováno v:
Breast Care. 17:508-513
Introduction: Noninterventional study (NIS) on application and effectiveness of primary G-CSF prophylaxis with lipegfilgrastim in primary breast cancer patients undergoing dose-dense (dd) or intense-dose-dense (idd) chemotherapy (CTx) regimen in dail
Autor:
Bernd Schmid, Joachim Hipp
Publikováno v:
Organisationsberatung, Supervision, Coaching. 10:255-263
Der Artikel richtet sein Augenmerk auf die Bedeutung von Rahmenbedingungen und Kontrakt-bzw. Beziehungsklarungen, die notwendig sind, damit Coaching positive Wirkungen in Organisationen entfalten kann. Dabei werden insbesondere Fallen beschrieben, di
Autor:
Guy van Hazel, Valentina Ivanova, Joachim Hipp, Mario Lazzarino, Irina V. Poddubnaya, Andrej Vranowsky, Anthony D. Ho, Mathias Witzens-Harig, Robin Foà, Dalton Fa Chamone, Klaus Ruffert, Jacob M. Rowe, Stefan Oertel
Publikováno v:
Blood. 114:3756-3756
Abstract 3756 Poster Board III-692 Background Rituximab maintenance therapy applied for two years after a successful induction with immuno-chemotherapy with rituximab has become standard of care in patients with relapsed follicular lymphoma (FL). The
Autor:
Mathias Witzens-Harig, Michael Wenger, Joachim Hipp, Nikolai Nikolov, Daniel Thurley, Anthony D. Ho, Stefan Oertel, Manfred Hensel
Publikováno v:
Blood. 112:1998-1998
Background: The clinical benefit of improved PFS and OS for rituximab maintenance in follicular lymphoma (FL) has been reported in five randomized trials. The primary objective of the current study is to extend the safety database for rituximab maint